Jill Rollet is the Executive Editor of Endocrine Today, a publication associated with Healio. With a focus on endocrinology and related topics, Jill covers a wide range of articles including research updates, clinical guidelines, and interviews with experts in the field. Her work aims to provide healthcare professionals with the latest information and insights in the field of endocrinology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jill Rollet's coverage primarily focuses on healthcare, scientific developments, and health & wellbeing topics. She frequently cites data and provides expert commentary in her articles.
Given the nature of Jill's coverage, she is likely to be interested in pitches that offer access to credible experts who can provide insights into the latest scientific or medical research within women’s health, reproductive health, diabetes, menopause and related areas. Pitches should emphasize providing exclusive access to new data or studies as well as opportunities for expert commentary on relevant healthcare issues.
As there is no specific geographic focus mentioned for Jill Rollet's coverage area,pitches with international perspectives would likely be of interest given the global relevance of healthcare topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jill Rollet
SAN DIEGO — Semaglutide, a GLP-1 receptor agonist approved for treatment of obesity and type 2 diabetes, improved kidney metrics for adults with overweight and obesity without diabetes, according study data.“The FLOW trial demonstrated that semaglutide reduces the risk of a clinical kidney outcome in people with type 2 diabetes and chronic kidney disease. We had also shown previously
By: Sheila Deziel, Gina Brockenbrough, Jill Rollet
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Jeffrey Silberzweig, Jill Rollet, Gina Brockenbrough
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Michael Anger, Robert Kossmann, Facp Fasn, Jill Rollet
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Josh Friedman, Jill Rollet, Gina Brockenbrough
Nine months after the ransomware attack on the health payment processing company Change Healthcare, the far-reaching impacts on medical practices, providers and patients continue to be felt.
By: Gina Brockenbrough, Jill Rollet
Long-term albuminuria risks for U.S. adults with Asian/Pacific Islander ancestry who have diabetes and normal kidney function differ across ethnic subgroups, according to data published in Kidney Medicine
Key takeaways: ASN published guidance on managing obesity with kidney disease. Some kidney therapies may promote weight gain, and transplant often requires a weight cap.
By: Jill Rollet, Gina Brockenbrough
Since 2017, a safety-net health care system in Texas has become a large provider of home peritoneal dialysis to mostly uninsured/undocumented
By: Darcy K. Weidemann, Gina Brockenbrough, Jill Rollet
SAN DIEGO — In this video exclusive from ASN Kidney Week, Darcy K. Weidemann, MD, MHS, FAAP, a pediatric nephrologist at Children's Mercy
Healio has compiled a list of the most-read nephrology-related exclusive features in 2024.
(833) 317-6278 
